Keyword: Merck

News

Versum Materials Board of Directors Rejects Unsolicited Proposal from Merck

28.02.2019 - The Board of Directors of Tempe, Arizona-based electronic chemicals supplier Versum Materials has rejected Merck's unsolicited and non-binding proposal to acquire Versum for $48...

News

Merck KGaA Plans $70 Million US Research Hub

12.02.2019 - To expand its R&D footprint in the US, but also with an eye to global markets, German pharmaceuticals and chemicals group Merck is establishing a new innovation hub in Billerica...

News

Merck KGaA and GSK in Immunotherapy Pact

06.02.2019 - German and British drugmakers Merck KGaA and Glaxo SmoithKline have entered a global strategic alliance to jointly develop and commercialize M7824 (bintrafusp alfa), the German...

News

Merck KGaA Completes Consumer Health Sale

04.12.2018 - German pharmaceuticals, chemicals and laboratory products group Merck completed the sale of its Consumer Health business to US consumer products group Procter & Gamble (P&G) on Dec...

News

Merck KGaA to sell Reagent Arm to Luminex

01.11.2018 - Merck KGaA, the German pharmaceuticals, chemicals and laboratory science group, is selling its MilliporeSigma Flow Cytometry unit to Luminex, based at Austin, Texas, in the US. The...

News

EU Clears Merck’s Consumer Health Sale to P&G

31.08.2018 - The European Commission has approved the sale by Merck KGaA of its global consumer health business to Procter & Gamble (P&G). The regulator said it had no competition concerns...

News

Australia grants Merck KGaA CRISPR Patent

16.08.2018 - The Australian Patent Office has granted an application by Germany’s Merck KGaA to patent the use of paired CRISPR nickases. The Darmstadt-based group said, these “represent a...

News

FDA accepts Merck KGaA oral MS Filing

01.08.2018 - The US Food and Drug Administration has accepted the resubmission of Merck KGaA’s New Drug Application (NDA) for cladribine tablets as a potential treatment for patients with...